23 results
DEFM14A
DMKPQ
DMK Pharmaceuticals Corp
13 Apr 23
Proxy related to merger
4:52pm
and biological materials that have the potential to transmit disease, and our operations may produce hazardous waste. If we fail to comply with these laws
PREC14A
Hammann Jerald
23 Jun 21
Preliminary proxy with contested solicitation
4:17pm
generally; and/or (g) investigate the possibility of mismanagement, waste, and wrongdoing, including the breach of fiduciary duty to its shareholders
10-KT
EX-10.50
fo0q4qsembkfaefi206t
26 Mar 15
Annual report (with FYE transition)
12:00am
10-KT
csif3 sx94xl6s
26 Mar 15
Annual report (with FYE transition)
12:00am
424B4
aftd2rtv
16 Dec 13
Prospectus supplement with pricing info
12:00am
8-K
EX-10.1
qxvxr2510zruh4
7 Dec 09
Adamis Pharmaceuticals Announces Signing of Definitive Merger Agreement
12:00am
425
EX-2.1
9hxpp6ky9c
7 Dec 09
Business combination disclosure
12:00am
8-K
EX-2.1
wmw50k6832a
13 Feb 08
Cellegy Pharmaceuticals Announces Signing of
12:00am
425
EX-2.1
c0nw8xs u6qasmvo8p
13 Feb 08
Business combination disclosure
12:00am